CV Sciences (CVSI) Change in Accured Expenses (2011 - 2026)

CV Sciences has disclosed Change in Accured Expenses across 16 years of filings, most recently posting $92000.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $92000.0, up 118.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$764000.0 (up 14.83% YoY), and the FY2025 annual result was -$1.3 million, down 187.37% from the prior year.
• Change in Accured Expenses came in at $92000.0 for Q1 2026 at CV Sciences, up from -$266000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $193000.0 in Q3 2023 to a low of -$563000.0 in Q3 2025.
• The 5-year median for Change in Accured Expenses is -$187000.0 (2024), against an average of -$193352.9.
• Peak annual rise in Change in Accured Expenses reached 144.37% in 2023, while the deepest fall reached 1155.0% in 2023.
• CV Sciences' Change in Accured Expenses stood at -$20000.0 in 2022, then plunged by 1155.0% to -$251000.0 in 2023, then surged by 141.04% to $103000.0 in 2024, then plunged by 358.25% to -$266000.0 in 2025, then jumped by 134.59% to $92000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $92000.0 (Q1 2026), -$266000.0 (Q4 2025), and -$563000.0 (Q3 2025), per Business Quant data.